Time course of the development of nonalcoholic fatty liver disease in the otsuka long-evans tokushima fatty rat

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Song, Yi Sun ^a   Fang, Cheng Hu ^b,c   So, Byung Im ^a   Park, Jun Young ^a   Lee, Yonggu ^b   Shin, Jeong Hun ^b   Jun, Dae Won ^b   Kim, Hyuck ^b   Kim, Kyung Soo ^a,b  

^a Hanyang University   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HISTOPATHOLOGY; LIPOGENESIS; LIVER CELL DAMAGE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84878722041     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/342648     Document Type: Article

References (39)

1. Marchesini G., Brizi M., Blanchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A. J., Natale S., Forlani G., Melchionda N., Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001 50 8 1844 1850 2-s2.0-0035431018 (Pubitemid 33641605)
2. Angulo P., Nonalcoholic fatty liver disease. The New England Journal of Medicine 2002 346 16 1221 1231
3. Browning J. D., Szczepaniak L. S., Dobbins R., Nuremberg P., Horton J. D., Cohen J. C., Grundy S. M., Hobbs H. H., Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 40 6 1387 1395 2-s2.0-10644220306 10.1002/hep.20466 (Pubitemid 39657013)
4. Albano E., Mottaran E., Occhino G., Reale E., Vidali M., Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Alimentary Pharmacology and Therapeutics 2005 22 supplement 2 71 73 2-s2.0-27644510537 (Pubitemid 41564388)
5. Rector R. S., Thyfault J. P., Morris R. T., Laye M. J., Borengasser S. J., Booth F. W., Ibdah J. A., Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. The American Journal of Physiology 2008 294 3 G619 G626 2-s2.0-41549166521 10.1152/ajpgi.00428.2007 (Pubitemid 351468778)
6. Day C. P., James O. F. W., Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998 114 4 I 842 845 2-s2.0-0031947715 10.1016/S0016-5085(98) 70599-2 (Pubitemid 28160420)
7. Chae M. K., Park S. G., Song S. O., Kang E. S., Cha B. S., Lee H. C., Lee B. W., Pentoxifylline attenuates methionine- and choline-deficient-diet-induced steatohepatitis by suppressing TNF- expression and endoplasmic reticulum stress. Experimental Diabetes Research 2012 2012 8 762565 10.1155/2012/762565
8. Gauthier M. S., Favier R., Lavoie J. M., Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. The British Journal of Nutrition 2006 95 2 273 281 2-s2.0-33644890756 10.1079/BJN20051635
9. Ackerman Z., Oron-Herman M., Grozovski M., Rosenthal T., Pappo O., Link G., Sela B. A., Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 2005 45 5 1012 1018 2-s2.0-18244375243 10.1161/01.HYP.0000164570.20420.67 (Pubitemid 40628952)
10. Choi S. S., Diehl A. M., Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Current Opinion in Lipidology 2008 19 3 295 300 10.1097/MOL.0b013e3282ff5e55 (Pubitemid 351653569)
11. García-Ruiz I., Rodríguez-Juan C., Díaz-Sanjuan T., del Hoyo P., Colina F., Muñoz-Yagüe T., Solís-Herruzo J. A., Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 2006 44 3 581 591 2-s2.0-33748946183 10.1002/hep.21313 (Pubitemid 44433714)
12. Jung T. S., Kim S. K., Shin H. J., Jeon B. T., Hahm J. R., Roh G. S., -lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. Liver International 2012 32 10 1565 1573 10.1111/j.1478-3231.2012.02857.x
13. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T., Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992 41 11 1422 1428 2-s2.0-0026722931
14. Shima K., Zhu M., Mizuno A., Pathoetiology and prevention of NIDDM lessons from the OLETF rat. Journal of Medical Investigation 1999 46 3-4 121 129 2-s2.0-0032714403
15. Shoji E., Okumura T., Onodera S., Takahashi N., Harada K., Kohgo Y., Gastric emptying in OLETF rats not expressing CCK-A receptor gene. Digestive Diseases and Sciences 1997 42 5 915 919 2-s2.0-0030929128 10.1023/A: 1018860313674 (Pubitemid 27239780)
16. Nomoto S., Miyake M., Ohta M., Funakoshi A., Miyasaka K., Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor. Physiology and Behavior 1999 66 5 869 872 2-s2.0-0032974172 10.1016/S0031- 9384(99)00033-5 (Pubitemid 29281650)
17. Takiguchi S., Takata Y., Funakoshi A., Miyasaka K., Kataoka K., Fujimura Y., Goto T., Kono A., Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 1997 197 1-2 169 175 2-s2.0-0030845706 10.1016/S0378-1119(97) 00259-X (Pubitemid 27399890)
18. Kurita S., Takamura T., Ota T., Matsuzawa-Nagata N., Kita Y., Uno M., Nabemoto S., Ishikura K., Misu H., Ando H., Zen Y., Nakanuma Y., Kaneko S., Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. European Journal of Pharmacology 2008 588 2-3 316 324 2-s2.0-46549089538 10.1016/j.ejphar.2008.04.028
19. Rector R. S., Thyfault J. P., Uptergrove G. M., Morris E. M., Naples S. P., Borengasser S. J., Mikus C. R., Laye M. J., Laughlin M. H., Booth F. W., Ibdah J. A., Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. Journal of Hepatology 2010 52 5 727 736 2-s2.0-77951632831 10.1016/j.jhep.2009.11.030
20. Yang S. J., Choi J. M., Chae S. W., Kim W. J., Park S. E., Rhee E. J., Lee W. Y., Oh K. W., Park S. W., Kim S. W., Park C. Y., Activation of peroxisome proliferator-activated receptor γ by rosiglitazone increases Sirt6 expression and ameliorates hepatic steatosis in rats. PLoS ONE 2011 6 2 2-s2.0-79952032653 10.1371/journal.pone.0017057 e17057
21. Yeon J. E., Choi K. M., Baik S. H., Kim K. O., Lim H. J., Park K. H., Kim J. Y., Park J. J., Kim J. S., Bak Y. T., Byun K. S., Lee C. H., Reduced expression of peroxisome proliferator-activated receptor- may have an important role in the development of non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2004 19 7 799 804 2-s2.0-3242795074 10.1111/j.1440-1746.2004.03349.x (Pubitemid 38981403)
22. Seo Y. S., Kim J. H., Jo N. Y., Choi K. M., Baik S. H., Park J. J., Kim J. S., Byun K. S., Bak Y. T., Lee C. H., Kim A., Yeon J. E., PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. Journal of Gastroenterology and Hepatology 2008 23 1 102 109 2-s2.0-37249059359 10.1111/j.1440-1746.2006.04819.x (Pubitemid 350265194)
23. Borengasser S. J., Rector R. S., Uptergrove G. M., Exercise and omega-3 polyunsaturated fatty acid supplementation for the treatment of hepatic steatosis in hyperphagic OLETF rats. Journal of Nutrition and Metabolism 2012 2012 12 268680 10.1155/2012/268680
24. Guo Z., Bu S., Yu Y., Ghatnekar G., Wang M., Chen L., Bu M., Yang L., Zhu B., Feng Z., Huang Q., Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage. Journal of Diabetes and its Complications 2008 22 1 46 55 2-s2.0-37749020578 10.1016/j.jdiacomp.2006.08.005
25. Uno M., Kurita S., Misu H., Ando H., Ota T., Matsuzawa-Nagata N., Kita Y., Nabemoto S., Akahori H., Zen Y., Nakanuma Y., Kaneko S., Takamura T., Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology 2008 48 1 109 118 2-s2.0-47149097985 10.1002/hep.22338 (Pubitemid 351975536)
26. Kilkenny C., Browne W. J., Cuthill I. C., Emerson M., Altman D. G., Improving bioscience research reporting: the arrive guidelines for reporting animal research. PLoS Biology 2010 8 6 e1000412 2-s2.0-77954560533 10.1371/journal.pbio.1000412
27. Blom D., Yamin T. T., Champy M. F., Selloum M., Bedu E., Carballo-Jane E., Gerckens L., Luell S., Meurer R., Chin J., Mudgett J., Puig O., Altered lipoprotein metabolism in P2Y13 knockout mice. Biochimica et Biophysica Acta 2010 1801 12 1349 1360 2-s2.0-77957943566 10.1016/j.bbalip.2010.08.013
28. Fan Y. M., Raitakari O. T., Kähönen M., Hutri-kähönen N., Juonala M., Marniemi J., Viikari J., Lehtimäki T., Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the cardiovascular risk in young finns study. Clinical Genetics 2009 76 1 46 53 2-s2.0-67650901254 10.1111/j.1399-0004.2009. 01180.x
29. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
30. Out R., Hoekstra M., Habets K., Meurs I., De Waard V., Hildebrand R. B., Wang Y., Chimini G., Kuiper J., Van Berkel T. J. C., Van Eck M., Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 258 264 2-s2.0-38549139265 10.1161/ATVBAHA.107.156935 (Pubitemid 351161197)
31. Rector S. R., Thyfault J. P., Laye M. J., Morris T. R., Borengasser S. J., Uptergrove G. M., Chakravarthy M. V., Booth F. W., Ibdah J. A., Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Journal of Physiology 2008 586 part 17 4241 4249 2-s2.0-51749108218 10.1113/jphysiol.2008.156745
32. Moran T. H., Bi S., Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors. Philosophical Transactions of the Royal Society B 2006 361 1471 1211 1218 2-s2.0-33845325347 10.1098/rstb.2006.1857 (Pubitemid 44874229)
33. Kanemoto N., Hishigaki H., Miyakita A., Oga K., Okuno S., Tsuji A., Takagi T., Takahashi E. I., Nakamura Y., Watanabe T. K., Genetic dissection of "OLETF" a rat model for non-insulin-dependent diabetes mellitus. Mammalian Genome 1998 9 6 419 425 2-s2.0-7344236791 10.1007/s003359900789 (Pubitemid 28334392)
34. Oh Y. K., Joo K. W., Lee J. W., Jeon U. S., Lim C. S., Han J. S., Knepper M. A., Na K. Y., Altered renal sodium transporter expression in an animal model of type 2 diabetes mellitus. Journal of Korean Medical Science 2007 22 6 1034 1041
35. Sakano K., Takahashi M., Mutoh M., Niho N., Komiya M., Sato H., Tanaka T., Sugimura T., Wakabayashi K., Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus. Carcinogenesis 2007 28 10 2193 2198 2-s2.0-35148894480 10.1093/carcin/bgm114 (Pubitemid 47543381)
36. Matsuzaka T., Shimano H., Yahagi N., Kato T., Atsumi A., Yamamoto T., Inoue N., Ishikawa M., Okada S., Ishigaki N., Iwasaki H., Iwasaki Y., Karasawa T., Kumadaki S., Matsui T., Sekiya M., Ohashi K., Hasty A. H., Nakagawa Y., Takahashi A., Suzuki H., Yatoh S., Sone H., Toyoshima H., Osuga J. I., Yamada N., Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nature Medicine 2007 13 10 1193 1202 2-s2.0-34948904815 10.1038/nm1662 (Pubitemid 47530641)
37. Musso G., Gambino R., Cassader M., Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Progress in Lipid Research 2009 48 1 1 26 2-s2.0-57649214103 10.1016/j.plipres.2008.08.001
38. Kim Y. W., Kim Y. M., Yang Y. M., Kim T. H., Hwang S. J., Lee J. R., Kim S. C., Kim S. G., Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radical Biology and Medicine 2010 48 4 567 578 2-s2.0-74149092293 10.1016/j.freeradbiomed.2009.12.006
39. Han Y., Joe Y., Seo E., Lee S. R., Park M. K., Lee H. J., Kim D. K., The hyperleptinemia and ObRb expression in hyperphagic obese rats. Biochemical and Biophysical Research Communications 2010 394 1 70 74 2-s2.0-77949875989 10.1016/j.bbrc.2010.02.104